- 4-Week # shares bought: 5,000
- 4-Week # shares sold: 115,577
- 12-Week # shares bought: 5,000
- 12-Week # shares sold: 221,062
- 24-Week # shares bought: 5,000
- 24-Week # shares sold: 272,562
Cramer says CyberArk Software is doing well but he's avoiding Clovis Oncology.
Cramer says he doesn't understand the obsession some investors have with the Federal Reserve. Forget the Fed.
As the transportation sector struggles, one of these railroads is a great value and bet on future growth. Here is a comparison of their strengths and weaknesses.